Ian T. Forbes - Concepedia

Author

Ian T. Forbes

Also Known As

Forbes, I.T., I Forbes, I T Forbes, I. FORBES, I. Forbes, I. T. FORBES, I.T. FORBES, I.T. Forbes, Ian Forbes, Ian T Forbes

Publications

3.4K

Citations

H-Index

Concepts

All Affiliations

New Frontier GlaxoSmithKline (United Kingdom)Molecular Discovery (United Kingdom)University of Cambridge GlaxoSmithKline (United States)

About

Ian T. Forbes is an author at New Frontier specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	28	2.1K
2	Natural Sciences	17	18	1.2K
3	Biochemistry	17	19	1.2K
4	Engineering	6	6	179
5	Social Sciences	1	1	51

Ian T. Forbes

Publications

3.3K

Citations

H-Index

Page 1

	Year	Citations
SB 242084, a Selective and Brain Penetrant 5-HT 2C Receptor Antagonist G.A. Kennett, Martyn Wood, Fiona Bright, Neuropharmacology Sb 242084Molecular PharmacologyFunctional SelectivityMedicineReceptor Antagonist	1997	523
A Novel, Potent, and Selective 5-HT<sub>7</sub>Antagonist: (<i>R</i>)-3-(2-(2-(4-Methylpiperidin-1-yl)ethyl)pyrrolidine-1-sulfonyl)phenol (SB-269970) Peter J. Lovell, Steven M. Bromidge, Steven Dabbs, Journal of Medicinal Chemistry Molecular PharmacologyMedicinal ChemistryPharmaceutical ScienceTranslational PharmacologyBiochemistry	2000	248
<i>In vitro</i>and<i>in vivo</i>profile of SB 206553, a potent 5‐HT<sub>2C</sub>/5‐HT<sub>2B</sub>receptor antagonist with anxiolytic‐like properties G.A. Kennett, Martyn Wood, Fiona Bright, British Journal of Pharmacology	1996	240
Characterization of a CNS penetrant, selective M<sub>1</sub>muscarinic receptor agonist, 77‐LH‐28‐1 Christopher J. Langmead, Nigel Austin, Clive L. Branch, British Journal of Pharmacology	2008	131
SB‐656104‐A, a novel selective 5‐HT<sub>7</sub> receptor antagonist, modulates REM sleep in rats David R. Thomas, Sergio Melotto, Mario Massagrande, British Journal of Pharmacology	2003	119
Functional characterisation of the human cloned 5‐HT<sub>7</sub> receptor (long form); antagonist profile of SB‐258719 David R. Thomas, Susan A. Gittins, Lissa L. Collin, British Journal of Pharmacology	1998	115
Probing the Molecular Mechanism of Interaction between 4-n-Butyl-1-[4-(2-methylphenyl)-4-oxo-1-butyl]-piperidine (AC-42) and the Muscarinic M1 Receptor: Direct Pharmacological Evidence That AC-42 Is an Allosteric Agonist Christopher J. Langmead, Victoria A. H. Fry, Ian T. Forbes, Molecular Pharmacology	2005	107
Urinary erythrocyte morphology in the diagnosis of glomerular hematuria. D.F. Birch, K. F. Fairley, J. A. Whitworth, PubMed Glomerular DiseaseHealthy SubjectsRenal PathologyPathologyGlomerulonephritis	1983	105
(<i>R</i>)-3,<i>N</i>-Dimethyl-<i>N</i>-[1-methyl-3-(4-methylpiperidin-1-yl)propyl]benzenesulfonamide: The First Selective 5-HT<sub>7</sub>Receptor Antagonist Ian T. Forbes, Steven Dabbs, D. Malcolm Duckworth, Journal of Medicinal Chemistry Drug TargetAltmetric Attention ScorePharmacotherapyChemical BiologyPharmaceutical Chemistry	1998	102
SB-243213; a selective 5-HT2C receptor inverse agonist with improved anxiolytic profile: lack of tolerance and withdrawal anxiety Martyn Wood, Charlie Reavill, Brenda Trail, Neuropharmacology Molecular PharmacologyWithdrawal AnxietyPsychiatryFunctional SelectivityAddiction	2001	100

Page 1